Kaya, A. Et Al. 2013. Rosuvastatin versus Atorvastatin to prevent Contrast induced Nephropathy in patients undergoing primary percutaneous coronary intervention (ROSA-CIN trial). Acta Cardiologica , vol.68, no.5 , 488-494.

Kaya, A., Kurt, M., Tanboǧa, I. H., Işik, T., Ekinci, M., Aksakal, E., ... Kaya, Y.(2013). Rosuvastatin versus Atorvastatin to prevent Contrast induced Nephropathy in patients undergoing primary percutaneous coronary intervention (ROSA-CIN trial). Acta Cardiologica , vol.68, no.5, 488-494.

Kaya, Ahmet Et Al. "Rosuvastatin versus Atorvastatin to prevent Contrast induced Nephropathy in patients undergoing primary percutaneous coronary intervention (ROSA-CIN trial)," Acta Cardiologica , vol.68, no.5, 488-494, 2013

Kaya, Ahmet Et Al. "Rosuvastatin versus Atorvastatin to prevent Contrast induced Nephropathy in patients undergoing primary percutaneous coronary intervention (ROSA-CIN trial)." Acta Cardiologica , vol.68, no.5, pp.488-494, 2013

Kaya, A. Et Al. (2013) . "Rosuvastatin versus Atorvastatin to prevent Contrast induced Nephropathy in patients undergoing primary percutaneous coronary intervention (ROSA-CIN trial)." Acta Cardiologica , vol.68, no.5, pp.488-494.

@article{article, author={Ahmet Kaya Et Al. }, title={Rosuvastatin versus Atorvastatin to prevent Contrast induced Nephropathy in patients undergoing primary percutaneous coronary intervention (ROSA-CIN trial)}, journal={Acta Cardiologica}, year=2013, pages={488-494} }